Updates from FDA

APhA Staff

Almost all women experience uncomfortable mild symptoms before the onset of menses.

Mary Warner

Berberine supplements are making waves as an appetite suppressant and metabolic support.

Mickie Cathers

FDA intends to add new warnings to all opioid pain medications to emphasize the risks of long-term use, including a summary of study results showing the potential for addiction, misuse, and overdose during long-term use; stronger warnings about higher doses; and more.

Loren Bonner

During ACIP’s September 2025 meeting, members voted not to support a universal COVID-19 vaccine recommendation going forward.

Loren Bonner